212 related articles for article (PubMed ID: 25583568)
21. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy.
Park SY; Kang S; Park JM; An HJ; Oh DH; Kim JI
Brachytherapy; 2019; 18(2):224-232. PubMed ID: 30528742
[TBL] [Abstract][Full Text] [Related]
22. Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy.
Stenhouse K; Roumeliotis M; Ciunkiewicz P; Martell K; Quirk S; Banerjee R; Doll C; Phan T; Yanushkevich S; McGeachy P
Brachytherapy; 2024; 23(3):368-376. PubMed ID: 38538415
[TBL] [Abstract][Full Text] [Related]
23. Gafchromic film dosimetry of a new HDR 192Ir brachytherapy source.
Ayoobian N; Asl AS; Poorbaygi H; Javanshir MR
J Appl Clin Med Phys; 2016 Mar; 17(2):194-205. PubMed ID: 27074483
[TBL] [Abstract][Full Text] [Related]
24. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators.
Chibani O; C-M Ma C
Med Phys; 2014 May; 41(5):051712. PubMed ID: 24784378
[TBL] [Abstract][Full Text] [Related]
25. Commissioning of a 3D image-based treatment planning system for high-dose-rate brachytherapy of cervical cancer.
Kim Y; Modrick JM; Pennington EC; Kim Y
J Appl Clin Med Phys; 2016 Mar; 17(2):405-426. PubMed ID: 27074463
[TBL] [Abstract][Full Text] [Related]
26. Comparison of planned and measured rectal dose in-vivo during high dose rate Cobalt-60 brachytherapy of cervical cancer.
Zaman ZK; Ung NM; Malik RA; Ho GF; Phua VC; Jamalludin Z; Baharuldin MT; Ng KH
Phys Med; 2014 Dec; 30(8):980-4. PubMed ID: 25086486
[TBL] [Abstract][Full Text] [Related]
27. Radiochromic film-based quality assurance for CT-based high-dose-rate brachytherapy.
Asgharizadeh S; Bekerat H; Syme A; Aldelaijan S; DeBlois F; Vuong T; Evans M; Seuntjens J; Devic S
Brachytherapy; 2015; 14(4):578-85. PubMed ID: 25865477
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of using multiple-dwell positions in
Tien CJ; Pinkham DW; Chen ZJ
Brachytherapy; 2020; 19(4):532-543. PubMed ID: 32327342
[TBL] [Abstract][Full Text] [Related]
29. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of rectal dose discrepancies between planned and in vivo dosimetry using MOSkin detector and PTW 9112 semiconductor probe during
Jamalludin Z; Jong WL; Malik RA; Rosenfeld AB; Ung NM
Phys Med; 2020 Jan; 69():52-60. PubMed ID: 31830631
[TBL] [Abstract][Full Text] [Related]
31. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer.
Price MJ; Gifford KA; Horton JL; Eifel PJ; Gillin MT; Lawyer AA; Mourtada F
Med Phys; 2009 Sep; 36(9):4147-55. PubMed ID: 19810488
[TBL] [Abstract][Full Text] [Related]
32. A treatment planning study comparing HDR and AGIMRT for cervical cancer.
Wahab SH; Malyapa RS; Mutic S; Grigsby PW; Deasy JO; Miller TR; Zoberi I; Low DA
Med Phys; 2004 Apr; 31(4):734-43. PubMed ID: 15124990
[TBL] [Abstract][Full Text] [Related]
33. Positional and angular tracking of HDR
Aldelaijan S; Devic S; Bekerat H; Papaconstadopoulos P; Schneider J; Seuntjens J; Cormack RA; Buzurovic IM
Med Phys; 2020 Dec; 47(12):6122-6139. PubMed ID: 33064876
[TBL] [Abstract][Full Text] [Related]
34. Dose comparison between TG-43-based calculations and radiochromic film measurements of the Freiburg flap applicator used for high-dose-rate brachytherapy treatments of skin lesions.
Aldelaijan S; Bekerat H; Buzurovic I; Devlin P; DeBlois F; Seuntjens J; Devic S
Brachytherapy; 2017; 16(5):1065-1072. PubMed ID: 28735877
[TBL] [Abstract][Full Text] [Related]
35. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
36. Evaluation and mitigation of potential errors in radiochromic film dosimetry due to film curvature at scanning.
Palmer AL; Bradley DA; Nisbet A
J Appl Clin Med Phys; 2015 Mar; 16(2):5141. PubMed ID: 26103181
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of applicator tip reconstruction in MRI-guided interstitial 192Ir-high-dose-rate brachytherapy of liver tumors.
Wybranski C; Eberhardt B; Fischbach K; Fischbach F; Walke M; Hass P; Röhl FW; Kosiek O; Kaiser M; Pech M; Lüdemann L; Ricke J
Radiother Oncol; 2015 Apr; 115(1):72-7. PubMed ID: 25779722
[TBL] [Abstract][Full Text] [Related]
38. Dosimetric assessment of an air-filled balloon applicator in HDR vaginal cuff brachytherapy using the Monte Carlo method.
Jiang H; Badkul R; Pokhrel D
J Appl Clin Med Phys; 2018 May; 19(3):101-107. PubMed ID: 29493101
[TBL] [Abstract][Full Text] [Related]
39. Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefits of intraoperative ultrasound guidance.
Davidson MT; Yuen J; D'Souza DP; Radwan JS; Hammond JA; Batchelar DL
Brachytherapy; 2008; 7(3):248-53. PubMed ID: 18635025
[TBL] [Abstract][Full Text] [Related]
40. A comparison of HDR near source dosimetry using a treatment planning system, Monte Carlo simulation, and radiochromic film.
Amoush A; Luckstead M; Lamba M; Elson H; Kassing W
Med Dosim; 2013; 38(2):160-4. PubMed ID: 23246195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
